SLA 0.00% $3.34 silk laser australia limited

ropren misses deadline

  1. 580 Posts.
    The Russian Ministry of Health is finally standing up for itself. Taking on untested drugs without proven efficacy in Phase III trials would be totally irresponsible.

    I hope that whomever leaked the "formality" of an approval to Solagran gets the sack. There is no way that this drug can be approved when the possibility of side-effects is completely unknown. This smells of corruption.
 
watchlist Created with Sketch. Add SLA (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.